Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$0.69 - $1.21 $476 - $836
-691 Reduced 5.52%
11,832 $11,000
Q1 2022

May 17, 2022

BUY
$1.02 - $3.8 $12,773 - $47,587
12,523 New
12,523 $15,000
Q4 2021

Feb 17, 2022

SELL
$3.26 - $4.66 $68,264 - $97,580
-20,940 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$4.08 - $5.66 $85,435 - $118,520
20,940 New
20,940 $94,000
Q2 2021

Sep 17, 2021

SELL
$5.01 - $7.48 $170,294 - $254,252
-33,991 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$7.19 - $14.95 $244,395 - $508,165
33,991 New
33,991 $254,000
Q1 2018

May 14, 2018

SELL
$9.47 - $12.98 $186,161 - $255,160
-19,658 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$8.45 - $17.48 $166,110 - $343,621
19,658
19,658 $191,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.